Variant report
Variant | esv3451356 |
---|---|
Chromosome Location | chr2:116073771-116101275 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572548357 | chr2:116073808-116073809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541430898 | chr2:116073823-116073824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181483387 | chr2:116073840-116073841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2030172 | chr2:116073860-116073861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575013368 | chr2:116073863-116073864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs386649413 | chr2:116073904-116073905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191865389 | chr2:116073905-116073906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4574126 | chr2:116073912-116073913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183965370 | chr2:116073926-116073927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs13018346 | chr2:116073978-116073979 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs559780980 | chr2:116073985-116073986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72840715 | chr2:116074055-116074056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548617791 | chr2:116074066-116074067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35896960 | chr2:116074075-116074076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376162986 | chr2:116074120-116074121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs36065374 | chr2:116074122-116074123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568537878 | chr2:116074154-116074155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115671834 | chr2:116074199-116074200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550733313 | chr2:116074231-116074232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570594146 | chr2:116074250-116074251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527530158 | chr2:116074251-116074252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs908599 | chr2:116074274-116074275 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs570285483 | chr2:116074283-116074284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552799605 | chr2:116074312-116074313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566441540 | chr2:116074327-116074328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79549266 | chr2:116074354-116074355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532103810 | chr2:116074379-116074380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186088159 | chr2:116074426-116074427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549624484 | chr2:116074432-116074433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2420814 | chr2:116074476-116074477 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs544011176 | chr2:116074494-116074495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35319906 | chr2:116074508-116074509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77756690 | chr2:116074515-116074516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367866067 | chr2:116074552-116074553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577412371 | chr2:116074558-116074559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546381759 | chr2:116074593-116074594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560052928 | chr2:116074626-116074627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149472681 | chr2:116074661-116074662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528816518 | chr2:116074698-116074699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542221541 | chr2:116074738-116074739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562097637 | chr2:116074771-116074772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577234244 | chr2:116074802-116074803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs3069645 | chr2:116074894-116074895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531023361 | chr2:116074955-116074956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs36035018 | chr2:116075022-116075023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189797457 | chr2:116075095-116075096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562184650 | chr2:116075106-116075107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115522664 | chr2:116075151-116075152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532940816 | chr2:116075186-116075187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148408128 | chr2:116075209-116075210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Mental retardation | 17621639 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:116068000-116083000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:116070600-116082800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr2:116079800-116080400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:116084000-116085400 | Enhancers | Fetal Intestine Large | intestine |
5 | chr2:116099800-116100400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr2:116100400-116103800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |